• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

Introduction to 2,6-Dimethylbenzaldehyde Oxime (CAS No. 55882-62-7)

2,6-Dimethylbenzaldehyde Oxime, identified by the Chemical Abstracts Service Number (CAS No.) 55882-62-7, is a significant organic compound that has garnered attention in the field of chemical and pharmaceutical research. This compound belongs to the class of oxime derivatives, which are widely studied for their diverse applications in synthetic chemistry, medicinal chemistry, and material science. The unique structural features of 2,6-Dimethylbenzaldehyde Oxime make it a valuable intermediate in the synthesis of various pharmacologically active molecules and functional materials.

The molecular structure of 2,6-Dimethylbenzaldehyde Oxime consists of a benzene ring substituted with two methyl groups at the 2- and 6-positions, along with an oxime functional group (-NOH) attached to the aldehyde carbon. This configuration imparts distinct chemical properties that contribute to its reactivity and utility in synthetic transformations. The presence of electron-donating methyl groups enhances the electrophilicity of the benzene ring, making it more susceptible to nucleophilic aromatic substitution reactions. Additionally, the oxime group introduces a polar functional moiety that can participate in hydrogen bonding and coordination interactions, further expanding its potential applications.

In recent years, 2,6-Dimethylbenzaldehyde Oxime has been explored as a key intermediate in the development of novel pharmaceuticals. Its structural framework serves as a scaffold for designing molecules with specific biological activities. For instance, oxime derivatives have been investigated for their potential as kinase inhibitors, which are crucial in targeting various diseases, including cancer and inflammatory disorders. The aldehyde functionality in 2,6-Dimethylbenzaldehyde Oxime allows for further derivatization through condensation reactions, enabling the synthesis of complex heterocyclic compounds that exhibit enhanced pharmacological properties.

Moreover, 2,6-Dimethylbenzaldehyde Oxime has found applications in material science, particularly in the synthesis of organic semiconductors and liquid crystals. The rigid aromatic core and the polar oxime group contribute to its ability to form ordered molecular assemblies, which are essential for applications in optoelectronic devices. Recent studies have demonstrated its utility in creating novel polymers with improved thermal stability and mechanical strength. These advancements highlight the versatility of 2,6-Dimethylbenzaldehyde Oxime as a building block for advanced materials.

The synthesis of 2,6-Dimethylbenzaldehyde Oxime typically involves the reaction of 2,6-dimethylaniline with an aldehyde source followed by condensation with hydroxylamine hydrochloride. This process yields the desired oxime derivative with high purity and yield under optimized conditions. The reaction can be further refined using catalytic methods or green chemistry approaches to minimize waste and improve sustainability. Such methodologies align with the growing emphasis on environmentally friendly synthetic routes in industrial applications.

Recent research has also explored the catalytic oxidation of 2,6-Dimethylbenzaldehyde Oxime to produce valuable intermediates for drug synthesis. The oxidation products can be selectively modified to generate molecules with different biological activities. For example, nitration or sulfonylation reactions on the aromatic ring can introduce additional functional groups that enhance binding affinity to biological targets. These transformations underscore the importance of 2,6-Dimethylbenzaldehyde Oxime as a versatile precursor in medicinal chemistry.

The spectroscopic and analytical characterization of 2,6-Dimethylbenzaldehyde Oxime is critical for ensuring its purity and consistency in industrial applications. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy, and mass spectrometry (MS) are routinely employed to confirm its structure and identify any impurities. These analytical methods provide essential data for quality control and help ensure that the compound meets stringent regulatory standards for pharmaceutical use.

In conclusion,2,6-Dimethylbenzaldehyde Oxime (CAS No. 55882-62-7) is a multifaceted compound with significant potential in pharmaceuticals and materials science. Its unique structural features enable diverse synthetic transformations that yield valuable intermediates for drug development and advanced materials. As research continues to uncover new applications for this compound,2,6-Dimethylbenzaldehyde Oxime is poised to play an increasingly important role in addressing global challenges in health and technology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)